SAINT® clinical trials
SAINT is cleared for the treatment of adults with major depressive disorder (MDD) who have failed to achieve satisfactory improvement from prior antidepressant medication. The following studies involve investigational uses of the SAINT system and have not been approved by the FDA. The safety and effectiveness of SAINT for these investigational uses have not been established.
PPD
Magnus Medical
A Randomized Controlled Multi-Site Trial Evaluating SAINT for Postpartum Depression
RECRUITING | ClinicalTrials.gov ID: NCT07210255
TRD
Investigator
Psilocybin rTMS for Treatment Resistant Depression (PSILOBSD)
RECRUITING | ClinicalTrials.gov ID: NCT06132178
MDD
Investigator
Accelerated Intermittent Theta Burst in Treatment-Naive Adolescents (SAINT-KID)
RECRUITING | ClinicalTrials.gov ID: NCT06523439
MDD
Magnus Medical
An Open Label Optimization Study to Assess the Effectiveness of the SAINT Neuromodulation System (NMS) to Treat Major Depressive Disorder
ACTIVE, NOT RECRUITING | ClinicalTrials.gov ID: NCT05819021
